A coalition of top medical organizations, including the Vaccine Integrity Project and the American Medical Association, has issued new vaccine guidance for the 2026‑27 respiratory season. Their independent review of current data informs recommendations for COVID‑19, RSV, and influenza shots, aiming to improve uptake and confidence. The groups emphasize the latest evidence on safety, effectiveness, and timing, urging clinicians to discuss these options with patients. This collaborative effort seeks to streamline decision‑making for both providers and the public as the next flu season approaches.
A coalition of leading medical groups has released its own vaccine recommendations for the 2026-27 respiratory viral season based on their independent evidence review of existing data. The Vaccine Integrity Project and American Medical Association (AMA) collaborated on evidence reviews for the vaccines targeting COVID-19, respiratory syncytial virus (RSV) and the flu. "The newest evidence...
